Role of hospital discharge statistics in evaluating the impact of statewide coordination of high blood pressure control programs

Under a contract with the National Heart, Lung, and Blood Institute, the Blue Cross and Blue Shield Associations carried out a demonstration project to determine how health insurers could utilize in-place systems and personnel to make worksite high blood pressure control programs more available to employee groups. When this project was initiated two and a half years ago, effective worksite-based programs had been developed in academic settings and tested in industry. Blue Cross and Blue Shield of Connecticut was selected by the national Blue Cross and Blue Shield Associations to serve as one of two demonstration test sites. The program is expanding to involve five additional Blue Cross and Blue Shield plans.

Download Full-text

Statement on the Role of Dietary Management in Hypertension Control

Occupational Health Nursing ◽

10.1177/216507998102901113 ◽

1981 ◽

Vol 29 (11) ◽

pp. 46-48

Keyword(s):

Blood Pressure ◽

High Blood Pressure ◽

Blood Pressure Control ◽

Pressure Control ◽

Blood Institute ◽

National High Blood Pressure ◽

National Heart Lung ◽

National Organizations ◽

Coordination And Collaboration

The National High Blood Pressure Education Program Coordinating Committee is a policymaking body whose purpose is to improve coordination and collaboration among national organizations involved in high blood pressure control. The Committee is composed of representatives of a number of professional and voluntary medical and health organizations. It is chaired and sponsored by the National Heart, Lung, and Blood Institute, National Institutes of Health. Among the activities of the Committee are defining priorities, exchanging views, promoting new initiatives in high blood pressure control, sponsoring a national conference, and coordinating High Blood Pressure Month in May of each year.

Download Full-text

Hypertension and the Kidney

Kidney Protection ◽

10.1093/med/9780190611620.003.0029 ◽

2019 ◽

pp. 287-294

Author(s):

Rupinder K. Sodhi ◽

Marie D. Philipneri ◽

Paul G. Schmitz

Keyword(s):

Blood Pressure ◽

High Blood Pressure ◽

Blood Pressure Control ◽

Blood Pressure Variability ◽

Renal Fibrosis ◽

Systolic Hypertension ◽

Pressure Control ◽

White Coat Hypertension ◽

Masked Hypertension

The prevalence of hypertension or high blood pressure (defined as systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg) worldwide exceeds 30%, with a steep increase in patients >50 years of age. For example, nearly 75% of patients >80 years of age exhibit high blood pressure. Despite considerable evidence demonstrating the benefits of antihypertensive therapy, <50% are controlled. This chapter will discuss the prevalence and detection of high blood pressure, with a special emphasis on the role of hypertension in progressive renal fibrosis. The authors cover classification and epidemiology of blood pressure control; the pitfalls of blood pressure control, including white coat hypertension, pseudohypertension, nocturnal blood pressure, masked hypertension, isolated systolic hypertension, and blood pressure variability; hypertensive kidney disease; and clinical studies assessing the renal effects of hypertension, concluding with a discussion of control of blood pressure and CKD progression and future directions in research and therapy.

Download Full-text